Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
1.880
+0.010 (0.53%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Larimar Therapeutics Employees
Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.
Employees
65
Change (1Y)
23
Growth (1Y)
54.76%
Revenue / Employee
n/a
Profits / Employee
-$1,240,062
Market Cap
120.37M
Employees Chart
LRMR News
- 22 days ago - Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich's Ataxia - GlobeNewsWire
- 3 months ago - Larimar Therapeutics: Positive Friedreich's Ataxia Data Can Only Get Better - Seeking Alpha
- 4 months ago - What's Going On With Larimar Therapeutics Stock On Tuesday? - Benzinga
- 4 months ago - Why Is Larimar Therapeutics Stock Trading Lower On Monday? - Benzinga
- 4 months ago - Larimar Therapeutics Announces Positive Initial Data from Ongoing Long-term Open Label Extension Study & Progress Across Nomlabofusp Program for Friedreich's Ataxia - GlobeNewsWire
- 5 months ago - Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results - GlobeNewsWire